Medtronic Can't Shake Investors' Claims Of Tainted Studies
A Minnesota federal judge on Monday refused to throw out the bulk of a securities class action alleging Medtronic Inc. downplayed problems with its bone graft products, saying the investors' allegations...To view the full article, register now.
Already a subscriber? Click here to view full article